Related Experiment Video
Updated: Jul 12, 2025
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Silica nanoparticles for brain cancer
Yuran Feng1, Yuxue Cao1, Ravi Singh1
1School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia.
Introduction:
Brain cancer is a debilitating disease with a poor survival rate. There are significant challenges for effective treatment due to the presence of the blood-brain barrier (BBB) and blood-tumor barrier (BTB) which impedes drug delivery to tumor sites. Many nanomedicines have been tested in improving both the survival and quality of life of patients with brain cancer with the recent focus on inorganic nanoparticles such as silica nanoparticles (SNPs). This review examines the use of SNPs as a novel approach for diagnosing, treating, and theranostics of brain cancer.
Areas Covered:
The review provides an overview of different brain cancers and current therapies available. A special focus on the key functional properties of SNPs is discussed which makes them an attractive material in the field of onco-nanomedicine. Strategies to overcome the BBB using SNPs are analyzed. Furthermore, recent advancements in active targeting, combination therapies, and innovative nanotherapeutics utilizing SNPs are discussed. Safety considerations, toxicity profiles, and regulatory aspects are addressed to provide an understanding of SNPs' translational potential.
Expert Opinion:
SNPs have tremendous prospects in brain cancer research. The multifunctionality of SNPs has the potential to overcome both the BBB and BTB limitations and can be used for brain cancer imaging, drug delivery, and theranostics. The insights provided will facilitate the development of next-generation, innovative strategies, guiding future research toward improved diagnosis, targeted therapy, and better outcomes in brain cancer patients.
Insights
Silica nanoparticles (SNPs) offer a promising solution for brain cancer treatment by overcoming the blood-brain barrier (BBB) and blood-tumor barrier (BTB). These nanoparticles enable advanced diagnostics, targeted drug delivery, and theranostics for improved patient outcomes.
Area of Science:
- Nanomedicine
- Oncology
- Materials Science
Background:
- Brain cancer presents significant therapeutic challenges due to the blood-brain barrier (BBB) and blood-tumor barrier (BTB), limiting drug efficacy.
- Nanomedicines, particularly inorganic nanoparticles like silica nanoparticles (SNPs), are being explored to enhance brain cancer treatment.
- This review focuses on the application of SNPs in addressing the limitations of current brain cancer therapies.
Purpose of the Study:
- To review the diverse applications of silica nanoparticles (SNPs) in brain cancer diagnosis, treatment, and theranostics.
- To analyze strategies for overcoming the BBB and BTB using SNPs.
- To discuss advancements in SNP-based nanotherapeutics, combination therapies, and safety considerations.
Main Methods:
- Comprehensive literature review of studies utilizing silica nanoparticles (SNPs) for brain cancer.
- Analysis of SNP properties relevant to overcoming biological barriers (BBB/BTB).
- Examination of recent research on active targeting, combination therapies, and theranostic approaches with SNPs.
Main Results:
- SNPs demonstrate significant potential in overcoming BBB and BTB limitations for brain cancer treatment.
- Multifunctional SNPs can be utilized for enhanced brain cancer imaging, targeted drug delivery, and theranostics.
- Recent advancements show promise for innovative SNP-based nanotherapeutics and combination strategies.
Conclusions:
- Silica nanoparticles (SNPs) represent a versatile platform with considerable prospects for advancing brain cancer research and clinical applications.
- The unique properties of SNPs facilitate improved diagnosis, targeted therapy, and theranostics, potentially leading to better patient outcomes.
- Further research and consideration of safety and regulatory aspects are crucial for the translational potential of SNPs in brain cancer care.
More Related Videos
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024